Results

Total Results: 425 records

Showing results for "laboratory".

301. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
     February 01, 2008 - in blood transfusions, extracorporeal circulation, and dialysis procedures and in blood samples for laboratory

302. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
     February 01, 2008 - in blood transfusions, extracorporeal circulation, and dialysis procedures and in blood samples for laboratory

303. Outcomes in COPD patients treated with theophylline (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/decide16final-mortality-risk-in-copd-pts-using-theophylline.pdf
     December 01, 2009 - Theophylline Level Among patients using theophylline at baseline, 28.4% had a theophylline laboratory

304. Outcomes in COPD patients treated with theophylline (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-management_research.pdf
     December 01, 2009 - Theophylline Level Among patients using theophylline at baseline, 28.4% had a theophylline laboratory

305. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix E (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-ape_0.xlsx
     August 08, 2017 - 0.21 to 2.93) GI events: 7.45 (0.46 to 119.74) Non-profit (Cochrane) Rostom, 2005 (Fair) Determine laboratory

306. final Fibromyalgia CER protocol_3-31-14 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fibromyalgia_research-protocol.pdf
     April 03, 2014 - there is no known pathophysiologic mechanism associated with fibromyalgia and therefore, no specific laboratory

307. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
     January 01, 2014 - to yield the PRP blood component at a facility (such as a hospital blood bank or blood processing laboratory … response to methotrexate were given tofacitinib 5 or 10 mg twice daily, adalimumab (Humira®; Abbott Laboratories

308. Association Between Outcomes and Dental Services in People Receiving Treatments That Cause Medication-Related Osteonecrosis of the Jaw: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-jaw-rapid-response.pdf
     May 01, 2025 - Clinical practice guidelines ● Primary studies must have sample size >10 ● Narrative reviews ● Laboratory … NOT (TI,AB(((animal$1 OR cell$4 OR computational OR ex-vivo OR in-silico OR in-vitro OR in-vivo OR laboratory

309. Disposition of Comments for Evidence Report 220 Health Information Exchange (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-information-exchange-disposition-160504.pdf
     December 15, 2015 - the authors intend to include electronic exchange of patient-level data including access to prior laboratory … Discussion A clear conclusion is stated: HIE can reduce utilization of health services in an ED (eg. laboratory

310. PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-antigen-3-gene_research.pdf
     April 01, 2013 - methodological/research expertise, clinical experience (urology, oncology, epidemiology), clinical laboratory … methodological/research expertise, clinical experience (urology, oncology, epidemiology), clinical laboratory

311. hemorrhage-postpartum-protocol-140611 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hemorrhage-postpartum_research-protocol.pdf
     June 11, 2014 - After PPH has been controlled, followup management varies and may include laboratory testing (e.g.,

312. Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
     September 02, 2016 - record number; or allocation by judgement of the clinician, preference of the participant, results of a laboratory

313. Methods Guide for Comparative Effectiveness Reviews - Avoiding Bias in Selecting Studies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias_methods.pdf
     February 01, 2013 - For example, cognitive testing using laboratory settings.

314. Research White Paper Multinational Registries Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
     February 01, 2018 - Because registries are observational, additional diagnostic or monitoring procedures such as laboratory

315. Disposition of Comments Report for Treatment of Depression During Pregnancy and the Postpartum Period (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_disposition-comments.pdf
     July 08, 2014 - interventions or no treatment) and measure outcomes of interest directly (not using proxy measures, e.g. laboratory

316. Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
     October 01, 2011 - 255, first paragraph under Atomoxetine, line 15, “There were no clinical meaningful differences in laboratory … values” should be changed to “There were no clinically meaningful differences in laboratory values

317. Emergency Medical Service/911 Workforce Mental or Behaviorial Health Issues (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/ems-911-workforce-topic-development-brief.pdf
     February 01, 2022 - Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic

318. Kidney-Disease-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
     January 01, 2012 - .13 Because CKD stages 1–3 usually progress asymptomatically, detection of early-stage CKD requires laboratory

319. S66 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
     October 01, 2007 - Clinical and laboratory effects of pro- longed therapy with sulfasalazine, gold or penicillamine: the

320. Renal-Cancer Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
     April 20, 2015 - in terms of clinical presentation, tumor characteristics (imaging), renal mass sampling results, or laboratory